© 2000 by Oxford University Press
Journal of the National Cancer Institute, Vol. 92, No. 9, 721-728,
May 3, 2000
© 2000 Oxford University Press
Human Kaposi's Sarcoma Cell-Mediated Tumorigenesis in Human Immunodeficiency Type 1 Tat-Expressing Transgenic Mice
Affiliations of authors: O. Prakash, Z.-Y. Tang, Y. He, M. S. Ali, R. Coleman (Laboratory of Molecular Oncology), J. Gill, G. Farr (Department of Pathology), Alton Ochsner Medical Foundation, New Orleans, LA; F. Samaniego, Institute of Human Virology and Greenbaum Cancer Center, University of Maryland, Baltimore.
Correspondence to: Om Prakash, Ph.D., Laboratory of Molecular Oncology, Alton Ochsner Medical Foundation, 1516 Jefferson Highway, New Orleans, LA 70121 (e-mail: oprakash{at}ochsner.org).
Background: The human immunodeficiency virus type 1 (HIV-1) transactivator (Tat) protein has been linked to the development and course of Kaposi's sarcoma (KS) associated with acquired immunodeficiency disease syndrome (AIDS–KS). Tat is an 86–101 amino-acid protein encoded by two exons. To evaluate the growth-promoting effects of Tat in AIDS–KS in vivo, we developed transgenic mice expressing the one-exon-encoded 72 amino-acid protein (Tat72) and the two-exon-encoded 86 amino-acid protein (Tat86). Methods: Human KS SLK cells were injected subcutaneously into CD4+ T-cell-depleted male mice, and the tumors that formed after 3–4 weeks were recovered and analyzed for the expression of Tat protein(s), different cytokine messenger RNAs (mRNAs), and matrix metalloproteinases (MMPs). All statistical tests were two-sided. Results: The average tumor weight was maximum in Tat86 mice (~600 mg) compared with Tat72 (~200 mg) and nontransgenic (~100 mg) mice (P<.005). Histologic examination of tumors showed spindle-shaped SLK cells with prominent infiltrates of inflammatory cells. All of the tumors from Tat mice expressed abundant Tat mRNA, suggesting that the infiltrating mouse cells actively expressed Tat. A comparison of the growth-promoting cytokines in the tumors from Tat86-transgenic and nontransgenic mice showed that the expression of the following cytokines was substantially increased in the tumors of the Tat86 mice: tumor necrosis factor-
, interleukin 6, interleukin 8, granulocyte–macrophage colony-stimulating factor, and basic fibroblast growth factor. Furthermore, these tumors showed abundant expression of a 105-kd MMP activity associated with infiltrates of host leukocytes in the lesions. Conclusion: Our in vivo data clearly suggest that extracellular Tat can contribute to the growth and tumorigenesis of human KS cells.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  B. Sahaf, K. Atkuri, K. Heydari, M. Malipatlolla, J. Rappaport, E. Regulier, L. A. Herzenberg, and L. A. Herzenberg Culturing of human peripheral blood cells reveals unsuspected lymphocyte responses relevant to HIV disease PNAS, April 1, 2008; 105(13): 5111 - 5116. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C Bellan, S Lazzi, G De Falco, A Nyongo, A Giordano, and L Leoncini Burkitt's lymphoma: new insights into molecular pathogenesis J. Clin. Pathol., March 1, 2003; 56(3): 188 - 192. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. R. Lane, J. Liu, P. J. Bock, D. Schols, M. J. Coffey, R. M. Strieter, P. J. Polverini, and D. M. Markovitz Interleukin-8 and Growth-Regulated Oncogene Alpha Mediate Angiogenesis in Kaposi's Sarcoma J. Virol., October 11, 2002; 76(22): 11570 - 11583. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Samaniego, D. Young, C. Grimes, V. Prospero, M. Christofidou-Solomidou, H. M. DeLisser, O. Prakash, A. A. Sahin, and S. Wang Vascular Endothelial Growth Factor and Kaposi's Sarcoma Cells in Human Skin Grafts Cell Growth Differ., August 1, 2002; 13(8): 387 - 395. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. W. Otieno, C. Banura, E. Katongole-Mbidde, J. L. Johnson, M. Ghannoum, A. Dowlati, R. Renne, E. Arts, C. Whalen, M. M. Lederman, et al. Therapeutic Challenges of AIDS-Related Non-Hodgkin's Lymphoma in the United States and East Africa J Natl Cancer Inst, May 15, 2002; 94(10): 718 - 732. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Barillari and B. Ensoli Angiogenic Effects of Extracellular Human Immunodeficiency Virus Type 1 Tat Protein and Its Role in the Pathogenesis of AIDS-Associated Kaposi's Sarcoma Clin. Microbiol. Rev., April 1, 2002; 15(2): 310 - 326. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Samaniego, S. Pati, J. E. Karp, O. Prakash, and D. Bose Human Herpesvirus 8 K1-Associated Nuclear Factor-kappa B-Dependent Promoter Activity: Role in Kaposi's Sarcoma Inflammation? J Natl Cancer Inst Monographs, December 1, 2000; 2000(28): 15 - 23. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Weiss and C. Boshoff Addressing Controversies Over Kaposi's Sarcoma J Natl Cancer Inst, May 3, 2000; 92(9): 677 - 679. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Rusnati, C. Urbinati, A. Caputo, L. Possati, H. Lortat-Jacob, M. Giacca, D. Ribatti, and M. Presta Pentosan Polysulfate as an Inhibitor of Extracellular HIV-1 Tat J. Biol. Chem., June 15, 2001; 276(25): 22420 - 22425. [Abstract] [Full Text] [PDF]
|
|